SI-235

General

Cell Line

hPSCreg name RGIe134-A
Cite as:
RGIe134-A (RRID:CVCL_B653)
Alternative name(s)
SI-235
Cell line type Human embryonic stem cell (hESC)
Similar lines
KIe051-A
(HS916)
Donor diseases:
Neurofibromatosis
RGIe049-A
(SI-137)
Donor diseases:
neurofibromatosis
RGIe050-A
(SI-138)
Donor diseases:
neurofibromatosis
RGIe051-A
(SI-139)
Donor diseases:
neurofibromatosis
RGIe052-A
(SI-140)
Donor diseases:
neurofibromatosis
Last update 30th August 2022
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Reproductive Genetics Institute (RGI)
Derivation country United States

External Databases

Cellosaurus CVCL_B653
Wikidata Q54950019

General Information

* Is the cell line readily obtainable for third parties?
No

Donor Information

General Donor Information

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
The donor is affected.
Disease associated phenotypes
  • Neurofibromatosis, Type I affected

Ethics

Alternatives to consent are available? Yes
Alternatives to consent
Alternative consent approval number
How may genetic information associated with the cell line be accessed?

hESC Derivation

Supernumerary embryos from IVF treatment?
Yes
PGD Embryo?
Yes

Culture Conditions

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
Alkaline Phosphatase
Yes
POU5F1 (OCT-4)
Yes
SSEA-3
Yes
SSEA-4
Yes
TRA 1-60
Yes
TRA 1-81
Yes
TRA 2-39
Yes

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
Passage number: 4

Other Genotyping (Cell Line)